Pregnancy and Oral Cancer (Literature Review)
Vol. 69 No. 6 (2023), REVIEWS
Vol. 69 No. 6 (2023)

Pregnancy and Oral Cancer (Literature Review)

REVIEWS
https://doi.org/10.37469/0507-3758-2023-69-6-1014-1020
Published 29.12.2023
Olga Dil
Research Institute of Oncology, Tomsk National Research Medical Center of the Russian Academy of Sciences
https://orcid.org/0000-0001-6562-7574
Denis Kulbakin
Research Institute of Oncology, Tomsk National Research Medical Center of the Russian Academy of Sciences
https://orcid.org/0000-0003-3089-5047
Evgeny Choinzonov
Research Institute of Oncology, Tomsk National Research Medical Center of the Russian Academy of Sciences
https://orcid.org/0000-0002-3651-0665
Alena L Chernyshova
Cancer Research Institute – a branch of Tomsk National Research Medical Center of the Russian Academy of Sciences
https://orcid.org/0000-0002-8194-2811
Alexander Chernyakov
Research Institute of Oncology, Tomsk National Research Medical Center of the Russian Academy of Sciences
https://orcid.org/0000-0003-0829-0340
pdf (Русский)

Keywords

oral cancer
pregnancy
tongue cancer
progression
gestation

How to Cite

Dil, O., Kulbakin, D., Choinzonov, E., Chernyshova, A. L., & Chernyakov, A. (2023). Pregnancy and Oral Cancer (Literature Review). Voprosy Onkologii, 69(6), 1014–1020. https://doi.org/10.37469/0507-3758-2023-69-6-1014-1020
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

The article provides a contemporary analysis of literature concerning the occurrence and specific characteristics of the clinical course of oral cancer (OC) during pregnancy. Currently, OC holds a prominent position among head and neck malignant neoplasms. The article explores the connection between the development of OC during pregnancy and various factors that align with existing theories. The findings reveal that OC in pregnant women tends to have a more unfavorable course: it progresses rapidly despite treatment and exhibits a heightened propensity for metastasis.

https://doi.org/10.37469/0507-3758-2023-69-6-1014-1020
pdf (Русский)

References

Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492.

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. https://doi.org/10.3322/caac.21660.

Состояние онкологической помощи нaселению России в 2021 году. Под ред. A.Д. Кaпринa, В.В. Стaринского, A.О. Шaхзaдовой. М.: МНИОИ им. П.A. Герценa − филиaл ФГБУ «НМИЦ рaдиологии» Минздрaвa России. 2022:239. ISBN 978-5-85502-275-9 [The state of oncological care for the Russian population in 2021. Kaprin AD, Starinsky VV, Shakhzadova AO, eds. Moscow: MCRI PA Herzen - branch FSBU «NMRC radiology» of Ministry of health of Russia. 2022:239. ISBN 978-5-85502-275-9 (In Russ.)].

Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48(11):3282-7.

Anis R, Gaballah K. Oral cancer in the UAE: a multicenter, retrospective study. Libyan J Med. 2013;8(1):21782. https://doi.org/10.3402/ljm.v8i0.21782.

Sargeran K, Murtomaa H, Safavi SM, et al. Malignant oral tumors in iran: ten-year analysis on patient and tumor characteristics of 1042 patients in Tehran. J Craniofac Surg. 2006;17(6):1230-3. https://doi.org/10.1097/01.scs.0000246728.23483.ce.

Ariyoshi Y, Shimahara M, Omura K, et al. Japanese Society of Oral and Maxillofacial Surgeons, 2002. Epidemiological study of malignant tumors in the oral and maxillofacial region: survey of member institutions of the Japanese Society of Oral and Maxillofacial Surgeons, 2002. Int J Clin Oncol. 2008;13(3):220-8. https://doi.org/10.1007/s10147-007-0756-9.

Brandizzi D, Gandolfo M, Velazco ML, et al. Clinical features and evolution of oral cancer: A study of 274 cases in Buenos Aires, Argentina. Med Oral Patol Oral Cir Bucal. 2008;13(9):E544-8. PMID: 18758396.

Johnson NW. Orofacial neoplasms: global epidemiology, risk factors and recommendations for research. Int Dent J. 1991;41(6):365-75.

Sarkaria JN, Harari PM. Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy. Head Neck. 1994;16(2):107-11. https://doi.org/10.1002/hed.2880160202.

Verschuur HP, Irish JC, O'Sullivan B, et al. A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck. Laryngoscope. 1999;109(2 Pt 1):249-58. https://doi.org/10.1097/00005537-199902000-00015.

Patel SC, Carpenter WR, Tyree S, et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol. 2011;29(11):1488-94. https://doi.org/10.1200/JCO.2010.31.7883.

Ng JH, Iyer NG, Tan MH, et al. Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study. Head Neck. 2017;39(2):297-304. https://doi.org/10.1002/hed.24589.

Satgunaseelan L, Allanson BM, Asher R, et al. The incidence of squamous cell carcinoma of the oral tongue is rising in young non-smoking women: An international multi-institutional analysis. Oral Oncol. 2020;110:104875. https://doi.org/10.1016/j.oraloncology.2020.104875.

O'Regan EM, Toner ME, Smyth PC, et al. Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patients. Head Neck. 2006;28(4):330-8. https://doi.org/10.1002/hed.20354.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. Lyon (FR): International Agency for Research on Cancer. 2007;(90):689.

Tommasino M. The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol. 2014;26:13-21. https://doi.org/10.1016/j.semcancer.2013.11.002.

Zur Hausen H. Papillomavirus infections: A major cause of human cancer. In: Zur Hausen H, ed. Infections causing human cancer. Weinheim, Germany: Wiley-VCH Verlag. 2006;145-243.

Dalianis T. Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review). Int J Oncol. 2014;44(6):1799-805. https://doi.org/10.3892/ijo.2014.2355.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. IARC Monogr Eval Carcinog Risks Hum. Lyon, France: WHO. 2011;261-301.

Singhvi HR, Malik A, Chaturvedi P. The role of chronic mucosal trauma in oral cancer: A review of literature. Indian J Med Paediatr Oncol. 2017;38(1):44-50. https://doi.org/10.4103/0971-5851.203510.

Rosenquist K, Wennerberg J, Schildt EB, et al. Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol. 2005;125(12):1327-36. https://doi.org/10.1080/00016480510012273.

Piemonte ED, Lazos JP, Brunotto M. Relationship between chronic trauma of the oral mucosa, oral potentially malignant disorders and oral cancer. J Oral Pathol Med. 2010;39(7):513-7. https://doi.org/10.1111/j.1600-0714.2010.00901.x.

Van der Waal I. Oral potentially malignant disorders: is malignant transformation predictable and preventable? Med Oral Patol Oral Cir Bucal. 2014;19(4):e386-90. doi: 10.4317/medoral.20205.

Garavello W, Spreafico R, Gaini RM. Oral tongue cancer in young patients: a matched analysis. Oral Oncol. 2007;43(9):894-7. https://doi.org/10.1016/j.oraloncology.2006.10.013.

Hilly O, Shkedy Y, Hod R, et al. Carcinoma of the oral tongue in patients younger than 30 years: comparison with patients older than 60 years. Oral Oncol. 2013;49(10):987-90. https://doi.org/10.1016/j.oraloncology.2013.07.005.

Kourelis K, Tsue T, Girod D, et al. Negative prognostic factors for head and neck cancer in the young. J BUON. 2013;18(2):459-64.

Hyam DM, Conway RC, Sathiyaseelan Y, et al. Tongue cancer: do patients younger than 40 do worse? Aust Dent J. 2003;48(1):50-4. https://doi.org/10.1111/j.1834-7819.2003.tb00009.x.

Zhang YY, Wang DC, Su JZ, et al. Clinicopathological characteristics and outcomes of squamous cell carcinoma of the tongue in different age groups. Head Neck. 2017;39(11):2276-2282. https://doi.org/10.1002/hed.24898.

Kourelis K, Tsue T, Girod D, et al. Negative prognostic factors for head and neck cancer in the young. J BUON. 2013;18(2):459-64.

Patel SC, Carpenter WR, Tyree S, et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol. 2011;29(11):1488-94. https://doi.org/10.1200/JCO.2010.31.7883.

Pentheroudakis G, Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer. 2006;42(2):126-40. https://doi.org/10.1016/j.ejca.2005.10.014.

Чернышова А.Л., Коломиец Л.А., Черняков А.А. и др. Особенности течения меланомы на фоне беременности. Вопросы онкологии. 2023;69(2):322-327 [Chernyshova AL, Kolomiets LA, Chernyakov AA, et al. Features of the course of melanoma during pregnancy. Voprosy Onkologii. 2023;69(2):322-7 (In Russ.)]. https://doi.org/10.37469/0507-3758-2023-69-2-322-327.

Yan JH, Liao CS, Hu YH. Pregnancy and nasopharyngeal carcinoma: a prognostic evaluation of 27 patients. Int J Radiat Oncol Biol Phys. 1984;10(6):851-5.

Bradley PJ, Raghavan U. Cancers presenting in the head and neck during pregnancy. Curr Opin Otolaryngol Head Neck Surg. 2004;12(2):76-81. https://doi.org/10.1097/00020840-200404000-00004.

Sumida T, Ishikawa A, Mori Y. Stimulation of the estrogen axis induces epithelial-mesenchymal transition in human salivary cancer cells. Cancer Genomics Proteomics. 2016;13(4):305-10.

Molteni A, Warpeha RL, Brizio-Molteni L, et al. Estradiol receptor-binding protein in head and neck neoplastic and normal tissue. Arch Surg. 1981;116(2):207-10. https://doi.org/10.1001/archsurg.1981.01380140053012.

Schuller DE, Abou-Issa H, Parrish R. Estrogen and progesterone receptors in head and neck cancer. Arch Otolaryngol. 1984;110(11):725-7. https://doi.org/10.1001/archotol.1984.00800370027006.

Budai B, Remenár E, Orosz Z, et al. Szteroidhormon-receptorok vizsgálata fej-nyak laphámrákban szenvedó betegeken [Steroid hormone receptors in squamous cell carcinoma of the head and neck (In Hung.)]. Orv Hetil. 1997;138(12):723-7.

Eliassen AM, Hauff SJ, Tang AL, et al. Head and neck squamous cell carcinoma in pregnant women. Head Neck. 2013;35(3):335-42. https://doi.org/10.1002/hed.22973.

Layton SA, Rintoul M, Avery BS. Oral carcinoma in pregnancy. Br J Oral Maxillofac Surg. 1992;30(3):161-4. https://doi.org/10.1016/0266-4356(92)90148-c.

Lasaridis N, Tilaveridis I, Karakasis D. Management of a carcinoma of the tongue during pregnancy: report of case. J Oral Maxillofac Surg. 1996;54(2):221-4. https://doi.org/10.1016/s0278-2391(96)90453-x.

Shibuya H, Saiot M, Horiuchi JI, et al. Treatment of malignant head and neck tumors during pregnancy--a report of 3 cases. Acta Oncol. 1987;26(3):237-8. https://doi.org/10.3109/02841868709091439.

Bu J, Bu X, Liu B, et al. Inhibition of metastasis of oral squamous cell carcinoma by anti-PLGF treatment. Tumour Biol. 2015;36(4):2695-701. https://doi.org/10.1007/s13277-014-2892-y.

Rebmann V, Switala M, Eue I, et al. Rapid evaluation of soluble HLA-G levels in supernatants of in vitro fertilized embryos. Hum Immunol. 2007;68(4):251-8. https://doi.org/10.1016/j.humimm.2006.11.003.

Ferreira LMR, Meissner TB, Tilburgs T, et al. HLA-G: At the interface of maternal-fetal tolerance. Trends Immunol. 2017;38(4):272-286. https://doi.org/10.1016/j.it.2017.01.009.

Ugurel S, Rebmann V, Ferrone S, et al. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer. 2001;92(2):369-76. https://doi.org/10.1002/1097-0142(20010715)92:2<369::aid-cncr1332>3.0.co;2-u.

Russell S, Angell T, Lechner M, et al. Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma. Head Neck Oncol. 2013;5(3):24.

D'Addio F, Riella LV, Mfarrej BG, et al. The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance. J Immunol. 2011;187(9):4530-41. https://doi.org/10.4049/jimmunol.1002031.

Feldman R, Gatalica Z, Knezetic J, et al. Molecular profiling of head and neck squamous cell carcinoma. Head Neck. 2016;38 Suppl 1(Suppl 1):E1625-38. https://doi.org/10.1002/hed.24290.

Hanna GJ, Woo SB, Li YY, et al. Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma. Int J Oral Maxillofac Surg. 2018;47(5):568-577. https://doi.org/10.1016/j.ijom.2017.09.006.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2023

Most read articles by the same author(s)